Cash & equivalents increased 273.7%
Cash & equivalents changed +273.7% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +273.7% from the comparable as-filed period.
Net income changed -72.4% from the comparable as-filed period.
Operating income changed -37.8% from the comparable as-filed period.
Operating margin changed -1567 basis points from the comparable as-filed period.
Research & development changed +200.0% from the comparable as-filed period.
Revenue changed +70.3% from the comparable as-filed period.
Selling, general & administrative changed +47.8% from the comparable as-filed period.
Inventory changed -4.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.